men are eligible for only 1 in 3 breast cancer clinical trials

In a recent post I discussed the underfunding of basic research on the male form of breast cancer, and advocated for 1% of breast cancer research funding to involve male disease, in proportion to 1% of breast cancer patients being men. So what about clinical trials? When it comes to eligibility for trials it is…

ESMO 2021: A Phase 3 Trial With a 2x2 Factorial Design in Men With De Novo Metastatic Castration-Sensitive Prostate Cancer: Overall Survival With Abiraterone Acetate Plus Prednisone in PEACE-1

Metastatic Breast Cancer in Men - Metastatic Breast Cancer Alliance

Roche Breaking down barriers to health equity in breast cancer

Breast cancer in NZ

CRISPR Clinical Trials: A 2023 Update - Innovative Genomics Institute (IGI)

5 things to expect after finishing chemotherapy

Breast Cancer: 3 Weeks of Radiation May Be Effective

FDA: More men needed in breast cancer clinical trials - TMC News

Triple-Negative Breast Cancer: the Current Aspects of Pathogenesis and Therapies

Breast cancer - Wikipedia

Invasive lobular breast cancer